share_log

HC Wainwright & Co. Reiterates Buy on Cidara Therapeutics, Maintains $6 Price Target

HC Wainwright & Co. Reiterates Buy on Cidara Therapeutics, Maintains $6 Price Target

HC Wainwright & Co.重申买入 Cidara Therapeutics,维持6美元的目标股价
Benzinga ·  2023/09/22 06:18

HC Wainwright & Co. analyst Ed Arce reiterates Cidara Therapeutics (NASDAQ:CDTX) with a Buy and maintains $6 price target.

HC Wainwright&Co.分析师埃德·阿尔斯重申Cidara Treateutics(纳斯达克:CDTX)的买入,并维持6美元的目标价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发